Vevo Therapeutics
Provider of an in vivo drug discovery platform and AI models. The company uses a mosaic in vivo drug discovery platform and next-generation AI models for in vivo data generation, and single-cell precision, to capture in vivo context of disease and to represent patient diversity in drug response over current in vitro assays. The company was founded in 2022 and headquartered in San Francisco, United States. It has…
Funding snapshot
About
Provider of an in vivo drug discovery platform and AI models. The company uses a mosaic in vivo drug discovery platform and next-generation AI models for in vivo data generation, and single-cell precision, to capture in vivo context of disease and to represent patient diversity in drug response over current in vitro assays. The company was founded in 2022 and headquartered in San Francisco, United States. It has raised $12M in seed funding, with backing from Wing Venture Capital, General Catalyst, Mubadala, AIX Ventures, and others. The company operates in the High Tech - Generative AI, Native AI - Generative AI, HealthTech - Life Sciences Tech space.
Business model
Life Sciences Tech > Research & Development > Drug Informatics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Statiq
Statiq is a manufacturer of electric vehicle charging hardware and operator of charging networks across India.
PhotoRoom
PhotoRoom is an AI-powered photo editing and product photography platform designed for e-commerce businesses of all sizes.
Moises
Moises is an AI-powered creative suite for musicians that provides tools for practice, performance, creation, and collaboration.
Krisp Technologies
Krisp is an AI-powered voice platform that provides noise cancellation, accent conversion, meeting assistance, and voice AI solutions for individuals, call centers, and developers.